SCHEMBL26828095

SCHEMBL26828095

Cn1c(-c2ccccc2)cc2ccncc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.64
▸ ATM Q13315 1/20 0.50
▸ AOC3 Q16853 4/20 0.46
▸ KCNH2 Q12809 3/20 0.46
▸ CYP19A1 P11511 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ CCNB2 O95067 1/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ CCNB1 P14635 1/20 0.45
▸ CDK5 Q00535 1/20 0.45
▸ CDK5R1 Q15078 1/20 0.45
▸ CCNB3 Q8WWL7 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ NTRK1 P04629 1/20 0.44
▸ NTRK3 Q16288 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ TOP2A P11388 1/20 0.42
▸ SLC2A1 P11166 1/20 0.42
▸ APP P05067 1/20 0.41
▸ NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22004468 0.80 USP2 (0.46) KMT2AATMAOC3KCNH2NTRK1
SCHEMBL7808056 0.79 KMT2A (0.67) KMT2AAOC3KCNH2CYP19A1ALDH1A1
SCHEMBL29433147 0.78 AOC3 (0.40) KMT2AAOC3KCNH2MAPTTOP2A
SCHEMBL15558669 0.78 MAPT (0.44) KMT2AATMAOC3KCNH2ALDH1A1
SCHEMBL29581156 0.78 KMT2A (1.00) KMT2ACYP19A1ALDH1A1HPGDMAPT
SCHEMBL214075 0.78 KMT2A (1.00) KMT2ACYP19A1ALDH1A1HPGDMAPT
SCHEMBL22004314 0.77 ACLY (0.51) KMT2AAOC3KCNH2NTRK1MAPT
SCHEMBL11687991 0.75 KMT2A (0.92) KMT2ACYP19A1ALDH1A1HPGDMAPT
SCHEMBL7119872 0.74 AOC3 (0.74) AOC3KCNH2
SCHEMBL10151406 0.73 MAPT (0.47) ATMAOC3KCNH2CYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230374006-A1 HETEROARYL COMPOUNDS AND USES THEREOF APRINOIA THERAPEUTICS LIMITED (CN) 2023-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230374006-A1 HETEROARYL COMPOUNDS AND USES THEREOF MAPT, APP, SLCO1B3 KMT2A 4329/4885ATM 1791/4885AOC3 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback